Cargando…

Atherogenic Index of Plasma and the Risk of In-Stent Restenosis in Patients with Acute Coronary Syndrome beyond the Traditional Risk Factors

Aim: Recently, the atherogenic index of plasma (AIP) has been proposed as a novel, reliable plasma atherogenicity marker. This study aimed to investigate the association of AIP with the risk of in-stent restenosis (ISR) in patients with acute coronary syndrome (ACS). Methods: This study retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Yong, Chen, Maolin, Liu, Kesen, Gao, Ang, Kong, Xiangyun, Liu, Yan, Han, Hongya, Li, Hong, Zhu, Huagang, Zhang, Jianwei, Zhao, Yingxin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9371759/ https://www.ncbi.nlm.nih.gov/pubmed/34497172 http://dx.doi.org/10.5551/jat.63136

Ejemplares similares

Triglyceride-glucose index is associated with in-stent restenosis in patients with acute coronary syndrome after percutaneous coronary intervention with drug-eluting stents
por: Zhu, Yong, et al.
Publicado: (2021)

Comparison of Drug-Coated Balloon Angioplasty vs. Drug-Eluting Stent Implantation for Drug-Eluting Stent Restenosis in the Routine Clinical Practice: A Meta-Analysis of Randomized Controlled Trials
por: Zhu, Yong, et al.
Publicado: (2021)

Atherogenic index of plasma and the risk of advanced subclinical coronary artery disease beyond traditional risk factors: An observational cohort study
por: Won, Ki‐Bum, et al.
Publicado: (2020)

Association of the atherogenic index of plasma with cardiovascular risk beyond the traditional risk factors: a nationwide population-based cohort study
por: Kim, Si Hyoung, et al.
Publicado: (2022)

Augmented glycaemic gap is a marker for an increased risk of post-infarct left ventricular systolic dysfunction
por: Zhu, Yong, et al.
Publicado: (2020)

Atherogenic index of plasma and coronary artery calcification progression beyond traditional risk factors according to baseline coronary artery calcium score
por: Won, Ki-Bum, et al.
Publicado: (2020)

The number of stents was an independent risk of stent restenosis in patients undergoing percutaneous coronary intervention
por: Tang, Long, et al.
Publicado: (2019)

Genetic risk model for in-stent restenosis of second-and third-generation drug-eluting stents
por: Liu, Yen-Wen, et al.
Publicado: (2021)

Long-term prognosis of chronic total occlusion treated by successful percutaneous coronary intervention in patients with or without diabetes mellitus: a systematic review and meta-analysis
por: Zhu, Yong, et al.
Publicado: (2021)

Drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
por: Dinesch, Violeta, et al.
Publicado: (2017)

Atherogenic Index of Plasma for the Assessment of Cardiovascular Risk Factors
por: Joob, Beuy, et al.
Publicado: (2017)

Viabahn for femoropopliteal in-stent restenosis
por: Al Shammeri, Owayed, et al.
Publicado: (2012)

Current Management of In-Stent Restenosis
por: Her, Ae-Young, et al.
Publicado: (2018)

Calcified in-stent restenosis in a venous stent
por: Schmidt, Jens-Ove, et al.
Publicado: (2015)

Hypersensitivity and in-stent restenosis in coronary stent materials
por: Hu, Wansong, et al.
Publicado: (2022)

Application of genetic risk score for in-stent restenosis of second- and third-generation drug-eluting stents in geriatric patients
por: Hsu, Yu-Ling, et al.
Publicado: (2023)

Therapeutic Strategy for In-Stent Restenosis Based on the Restenosis Pattern After Drug-Eluting Stent Implantation
por: Kim, Ki-Hun, et al.
Publicado: (2009)

Response to drug-eluting stent in-stent restenosis and re-restenosis: A hard time story
Publicado: (2017)

In-stent restenosis and longitudinal stent deformation: a case report
por: Si, Daoyuan, et al.
Publicado: (2020)

High levels of HB-EGF and interleukin-18 are associated with a high risk of in-stent restenosis
por: Jiang, Hua, et al.
Publicado: (2016)

Overlap stenting for in-stent restenosis after carotid artery stenting
por: Nishihori, Masahiro, et al.
Publicado: (2016)

The preoperative triglyceride-glucose index has a positive effect on predicting the risk of short-term restenosis after carotid artery stenting: a retrospective cohort study
por: Zhao, Shan-shan, et al.
Publicado: (2023)

The relationship of Charlson comorbidity index with stent restenosis and extent of coronary artery disease
por: Karabağ, Turgut, et al.
Publicado: (2018)

Identification of Risk Factors Influencing In-Stent Restenosis with Acute Coronary Syndrome Presentation
por: Cho, Jae Young
Publicado: (2017)

Risk factors associated with intra-stent restenosis after percutaneous coronary intervention
por: Alexandrescu, Dan-Mihai, et al.
Publicado: (2021)

Hemodynamic and Geometric Risk Factors for In-Stent Restenosis in Patients with Intracranial Atherosclerotic Stenosis
por: Song, Xiaowen, et al.
Publicado: (2022)

Predictive value of atherogenic index of plasma and atherogenic index of plasma combined with low-density lipoprotein cholesterol for the risk of acute myocardial infarction
por: Chen, Min, et al.
Publicado: (2023)

Risk investigation of in-stent restenosis after initial implantation of intracoronary drug-eluting stent in patients with coronary heart disease
por: Xi, Hongfei, et al.
Publicado: (2023)

In Stent Restenosis Predictors after Carotid Artery Stenting
por: Cosottini, Mirco, et al.
Publicado: (2010)

Intracoronary brachytherapy for in-stent restenosis of drug-eluting stents
por: Ohri, Nisha, et al.
Publicado: (2015)

Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis
por: Nojima, Yuhei, et al.
Publicado: (2014)

The Predictive Value of the Perivascular Adipose Tissue CT Fat Attenuation Index for Coronary In-stent Restenosis
por: Qin, Bin, et al.
Publicado: (2022)

Treatment of Femoropopliteal Artery In-stent Restenosis
por: Kim, Wonho, et al.
Publicado: (2018)

Aortoiliac reconstruction in the setting of in-stent restenosis
por: Natraj Setty, H. S., et al.
Publicado: (2017)

State-of-the-Art Stent Technology to Minimize the Risk of Stent Thrombosis and In-Stent Restenosis: Abluminal-Coated Biodegradable Polymer Drug-Eluting Stent
por: Kang, Dong Oh, et al.
Publicado: (2022)

Association between the triglyceride glucose index and coronary collateralization in coronary artery disease patients with chronic total occlusion lesions
por: Gao, Ang, et al.
Publicado: (2021)

Data on the expression and role of TREM-1 in the development of in-stent restenosis
por: Wang, Fang, et al.
Publicado: (2017)

Relationship between atherogenic index of plasma and stent thrombosis in patients with acute coronary syndrome
por: Abacıoğlu, Özge Özcan, et al.
Publicado: (2022)

Risk factors for in-stent restenosis after coronary stent implantation in patients with coronary artery disease: A retrospective observational study
por: Zhang, Juan, et al.
Publicado: (2022)

Middle and Distal Common Carotid Artery Stenting: Long-Term Patency Rates and Risk Factors for In-Stent Restenosis
por: Vértes, Miklós, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rpq60cmettgj8orv6fjo76hvj9